サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1800998

避妊用デバイス市場レポート：デバイスタイプ、エンドユーザー、流通チャネル、地域別、2025～2033年

Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
避妊用デバイス市場レポート：デバイスタイプ、エンドユーザー、流通チャネル、地域別、2025～2033年
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

避妊用デバイスの世界市場規模は2024年に150億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに231億米ドルに達し、2025年から2033年にかけて4.9%の成長率（CAGR）を示すと予測しています。家族計画の重要性に対する意識の高まり、意図しない妊娠の発生率の増加、家族計画プログラムを推進するための政府の取り組みや資金の増加が、市場を牽引する主な要因となっています。

避妊用デバイスは、個人やカップルが意図しない妊娠を防ぐのに不可欠なツールです。これらのデバイスは、受精プロセスを阻害することで妊娠を効果的に防止します。デバイスの種類によって、さまざまな素材や技術が用いられています。コンドームやダイアフラムなどのバリア法は、精子が卵子に到達するのを防ぐもので、一般的にラテックスやポリウレタン（PU）などで作られています。避妊ピル、注射、パッチなどのホルモン避妊薬には、女性の月経周期を調節し、排卵を防ぐ合成ホルモンが含まれています。一方、子宮内避妊器具（IUD）は銅製またはプラスチック製で、子宮に挿入して妊娠を防ぎます。避妊用デバイスには、個人個人が家族計画を立てたり、生殖に関する健康について十分な情報を得た上で選択したりするための自主性を提供するなど、数多くの利点があります。男女ともに使用することができ、避妊のための幅広い選択肢を提供します。正しく使用すれば一般的に安全で効果的であり、多くのデバイスは性感染症（STI）の予防や月経出血の減少など、その他の特典も提供します。

避妊用デバイスの市場動向：

避妊用デバイスの世界市場は、家族計画法に対する認識と採用の増加、意図しない妊娠の発生率の増加など、いくつかの要因によって牽引されています。さらに、家族計画プログラムを推進するための政府の取り組みや資金の増加、STIの急増が市場の成長を後押ししています。さらに、経口避妊薬、子宮内避妊具、コンドーム、皮下インプラントなど、さまざまな避妊用デバイスが入手可能であること、消費者の支出力が高まっていることも、市場成長を後押ししています。これとは別に、長時間作用型可逆避妊薬の開発、eコマース分野の拡大、製品イノベーションの動向が市場成長を促進しています。これに伴い、非ホルモン性避妊薬や天然避妊薬に対する需要の増加や、女性がコントロールできる避妊法の受け入れが急増していることも市場成長に寄与しています。その他、メーカーとヘルスケアプロバイダーとの提携や協力関係の増加、新興市場における流通網の拡大などが、市場の成長をさらに促進すると予想されます。

本レポートで扱う主な質問

  • 避妊用デバイスの世界市場規模は？
  • 2025年から2033年にかけての世界の避妊用デバイス市場の予想成長率は？
  • 避妊用デバイスの世界市場を牽引する主要因は？
  • 避妊用デバイスの世界市場におけるCOVID-19の影響は？
  • 避妊用デバイスの世界市場におけるデバイスタイプ別の区分は？
  • 避妊用デバイスの世界市場におけるエンドユーザー別の区分は？
  • 避妊用デバイスの世界市場を流通チャネル別に区分すると？
  • 避妊用デバイスの世界市場における主要地域は？
  • 避妊用デバイスの世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の避妊用デバイス市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：デバイスタイプ別

  • コンドーム
  • ペッサリー
  • 子宮頸キャップ
  • スポンジ
  • 膣リング
  • 子宮内避妊器具
  • その他

第7章 市場内訳：エンドユーザー別

  • 男性
  • 女性

第8章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • オンラインストア
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan Plc
    • Bayer AG
    • Church & Dwight Co. Inc.
    • CooperSurgical Inc.
    • Merck & Co.
    • Mylan Inc.
    • Pfizer Inc.
    • Reckitt Benckiser Group plc
    • Teva Pharmaceutical Industries Ltd.
    • The Female Health Company
図表

List of Figures

  • Figure 1: Global: Contraceptive Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Contraceptive Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Contraceptive Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Contraceptive Devices Market: Breakup by Device Type (in %), 2024
  • Figure 5: Global: Contraceptive Devices Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Contraceptive Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Contraceptive Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Contraceptive Devices (Condoms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Contraceptive Devices (Condoms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Contraceptive Devices (Diaphragms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Contraceptive Devices (Diaphragms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Contraceptive Devices (Cervical Caps) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Contraceptive Devices (Cervical Caps) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Contraceptive Devices (Sponges) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Contraceptive Devices (Sponges) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Contraceptive Devices (Vaginal Rings) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Contraceptive Devices (Vaginal Rings) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Contraceptive Devices (IUDs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Contraceptive Devices (IUDs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Contraceptive Devices (Other Device Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Contraceptive Devices (Other Device Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Contraceptive Devices (Male) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Contraceptive Devices (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Contraceptive Devices (Female) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Contraceptive Devices (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Contraceptive Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Contraceptive Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Contraceptive Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Contraceptive Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Contraceptive Devices (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Contraceptive Devices (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Contraceptive Devices (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Contraceptive Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: North America: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Asia-Pacific: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Europe: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Contraceptive Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Contraceptive Devices Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Contraceptive Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Contraceptive Devices Industry: SWOT Analysis
  • Figure 84: Global: Contraceptive Devices Industry: Value Chain Analysis
  • Figure 85: Global: Contraceptive Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Contraceptive Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Contraceptive Devices Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 3: Global: Contraceptive Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Contraceptive Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Contraceptive Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Contraceptive Devices Market: Competitive Structure
  • Table 7: Global: Contraceptive Devices Market: Key Players
目次
Product Code: SR112025A2841

The global contraceptive devices market size reached USD 15.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.

Contraceptive devices are essential tools that help individuals and couples prevent unintended pregnancies. These devices effectively prevent pregnancy by inhibiting the fertilization process. They are made using various materials and technologies, depending on the type of device. Barrier methods, such as condoms and diaphragms, prevent sperm from reaching the egg and are typically made of latex, polyurethane (PU), or other materials. Hormonal contraceptives, such as birth control pills, injections, and patches contain synthetic hormones that regulate the woman's menstrual cycle and prevent ovulation. On the other hand, intrauterine devices (IUDs) are made of either copper or plastic and are inserted into the uterus to prevent pregnancy. Contraceptive devices offer numerous advantages, such as providing individuals with the autonomy to plan their families and make informed choices about their reproductive health. They can be used by both men and women, offering a wide range of options for contraception. They are generally safe and effective when used correctly, and many devices also provide additional benefits, such as protection against sexually transmitted infections (STIs) or reduced menstrual bleeding.

Contraceptive Devices Market Trends:

The global contraceptive devices market is driven by several factors, including the increasing awareness and adoption of family planning methods and the growing incidence of unintended pregnancies. Moreover, the rising government initiatives and funding to promote family planning programs and the surging prevalence of STIs are boosting the market growth. Furthermore, the availability of various contraceptive devices, including oral contraceptives, intrauterine devices, condoms, and subdermal implants, and inflating consumer expenditure power are driving the market growth. Apart from this, the development of long-acting reversible contraceptives, the expansion of the e-commerce sector, and the inflating trend of product innovations are fueling the market growth. In line with this, the increasing demand for non-hormonal and natural contraceptives and the surging acceptance of female-controlled contraceptive methods are also contributing to the market growth. Other factors, such as the growing number of partnerships and collaborations between manufacturers and healthcare providers, as well as the expansion of distribution networks in emerging markets, are expected to propel the market growth further.

Key Market Segmentation:

Device Type Insights:

  • Condoms
  • Diaphragms
  • Cervical Caps
  • Sponges
  • Vaginal Rings
  • IUDs
  • Others

End User Insights:

  • Male
  • Female

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for contraceptive devices. Some of the factors driving the North America contraceptive devices market included increasing awareness and acceptance, technological advancements, government initiatives, and rising prevalence of STIs.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global contraceptive devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1.How big is the global contraceptive devices market?
  • 2.What is the expected growth rate of the global contraceptive devices market during 2025-2033?
  • 3.What are the key factors driving the global contraceptive devices market?
  • 4.What has been the impact of COVID-19 on the global contraceptive devices market?
  • 5.What is the breakup of the global contraceptive devices market based on the device type?
  • 6.What is the breakup of the global contraceptive devices market based on the end user?
  • 7.What is the breakup of the global contraceptive devices market based on the distribution channel?
  • 8.What are the key regions in the global contraceptive devices market?
  • 9.Who are the key players/companies in the global contraceptive devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Contraceptive Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Condoms
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Diaphragms
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cervical Caps
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Sponges
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vaginal Rings
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 IUDs
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Male
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Female
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan Plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Church & Dwight Co. Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 CooperSurgical Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Merck & Co.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Mylan Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Reckitt Benckiser Group plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 The Female Health Company
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis